Simulating glutaminolysis by artificially increasing the intracellular levels of αKG is known to induce tumor cell death in vivo (10Oncogene), although the involvement of mTORC1 and SQSTM1/p62 in this phenotype remains elusive. The gene discussed is SQSTM1; the disease is neoplasm.